Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of thrombotic risk factors among beta-thalassemia patients from Western Iran.

Journal of thrombosis and thrombolysis - 1 Dec 2008

Rahimi Zohreh, Ghaderi Mandana, Nagel Ronald L, Muniz Adriana

Abstract excerpt

BACKGROUND: There is evidence for increased risk of thrombosis in patients with beta-thalassemia intermedia and beta-thalassemia major. The present study investigated the prevalence of thromboembolic risk factors of prothrombin G20210A, factor V Leiden G1691A and methylentetrahydrofolate reductase (MTHFR) C677T, as well as the hematological and clinical profiles in beta-thalassemia major and intermedia patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Child
Share to Child, Preschool

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Frequency

Share to Genetic Predisposition to Disease

Share to Infant

Share to Polymorphism, Single Nucleotide

Share to Prevalence

Source

Identifiers

PMID: 17982733
DOI: 10.1007/s11239-007-0163-0

Genes

MTHFR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of thrombotic risk factors among beta-thalassemia patients from Western Iran.PMID 17982733Read ↗

The prevalence of factor V Leiden (G1691A), prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations in Jordanian patients with beta-thalassemia major.Semantic proximity Read ↗

Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.Semantic proximity Read ↗

Factor V Leiden G1691A, Prothrombin G20210A, and MTHFR C677T and A1298C Mutations in Patients With Sickle Cell Disease in Tunisia.Semantic proximity Read ↗

Splenectomy and thrombosis: the case of thalassemia intermedia.Semantic proximity Read ↗

Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians.Semantic proximity Read ↗

Genotype-phenotype correlation related to lipid profile in beta-thalassemia major and intermedia in southern Iran.Semantic proximity Read ↗

Congenital thrombotic risk factors in beta-thalassemia.Semantic proximity Read ↗

Plasma lipids and lipoproteins in children and young adults with major β-thalassemia from western Iran: influence of genotype.Semantic proximity Read ↗

Molecular characterization of a β-thalassemia intermedia patient presenting inferior vena cava thrombosis: interaction of the β-globin erythroid Krüppel-like factor binding site mutation with Hb E and α(+)-thalassemia.Semantic proximity Read ↗

Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.Semantic proximity Read ↗

Association between Different Polymorphic Markers and β-Thalassemia Intermedia in Central Iran.Semantic proximity Read ↗

Molecular basis of thalassemia intermedia in Iran.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.